Delayed
Bombay S.E.
05:14:19 2024-06-03 am EDT
|
5-day change
|
1st Jan Change
|
1,182
INR
|
+0.86%
|
|
+10.01%
|
+0.27%
|
Fiscal Period: March |
2019
|
2020
|
2022
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
18,102
|
16,309
|
73,379
|
38,701
|
45,770
|
-
|
Enterprise Value (EV)
1 |
18,102
|
16,309
|
82,216
|
38,701
|
45,770
|
45,770
|
P/E ratio
|
-
|
9.25
x
|
75.4
x
|
40.6
x
|
35
x
|
26.1
x
|
Yield
|
-
|
-
|
0.11%
|
-
|
0.17%
|
0.17%
|
Capitalization / Revenue
|
1.35
x
|
1
x
|
5.23
x
|
-
|
2.33
x
|
2.03
x
|
EV / Revenue
|
1.35
x
|
1
x
|
5.23
x
|
-
|
2.33
x
|
2.03
x
|
EV / EBITDA
|
8.29
x
|
6.09
x
|
37.9
x
|
-
|
12.3
x
|
10.8
x
|
EV / FCF
|
-
|
-
|
-24.1
x
|
-
|
18.1
x
|
20.6
x
|
FCF Yield
|
-
|
-
|
-4.14%
|
-
|
5.53%
|
4.86%
|
Price to Book
|
3.14
x
|
2.2
x
|
9.03
x
|
-
|
4.37
x
|
3.77
x
|
Nbr of stocks (in thousands)
|
39,063
|
39,063
|
39,063
|
39,063
|
39,063
|
-
|
Reference price
2 |
463.4
|
417.5
|
1,878
|
990.8
|
1,172
|
1,172
|
Announcement Date
|
5/9/19
|
6/23/20
|
5/5/22
|
5/2/24
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2022
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
13,410
|
16,306
|
14,037
|
-
|
19,669
|
22,583
|
EBITDA
1 |
2,184
|
2,680
|
1,938
|
-
|
3,717
|
4,223
|
EBIT
1 |
-
|
2,053
|
1,192
|
-
|
2,445
|
2,923
|
Operating Margin
|
-
|
12.59%
|
8.49%
|
-
|
12.43%
|
12.94%
|
Earnings before Tax (EBT)
1 |
-
|
2,313
|
1,328
|
-
|
1,765
|
2,362
|
Net income
1 |
-
|
1,763
|
973.8
|
949.1
|
1,308
|
1,751
|
Net margin
|
-
|
10.81%
|
6.94%
|
-
|
6.65%
|
7.75%
|
EPS
2 |
-
|
45.14
|
24.93
|
24.43
|
33.49
|
44.82
|
Free Cash Flow
1 |
-
|
-
|
-3,039
|
-
|
2,532
|
2,225
|
FCF margin
|
-
|
-
|
-21.65%
|
-
|
12.87%
|
9.85%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
68.12%
|
52.69%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
193.58%
|
127.07%
|
Dividend per Share
2 |
-
|
-
|
2.000
|
-
|
2.000
|
2.000
|
Announcement Date
|
5/9/19
|
6/23/20
|
5/5/22
|
5/2/24
|
-
|
-
|
Fiscal Period: March |
2022 Q1
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
---|
Net sales
1 |
-
|
-
|
3,769
|
3,888
|
EBITDA
1 |
-
|
-
|
475.8
|
585.7
|
EBIT
|
-
|
-
|
-
|
-
|
Operating Margin
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
406.7
|
-
|
Net income
|
1,169
|
249.5
|
299.1
|
-
|
Net margin
|
-
|
-
|
7.94%
|
-
|
EPS
2 |
-
|
-
|
-
|
5.740
|
Dividend per Share
|
-
|
-
|
-
|
-
|
Announcement Date
|
8/3/21
|
1/27/22
|
5/5/22
|
8/10/22
|
Fiscal Period: March |
2019
|
2020
|
2022
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
8,836
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
4.559
x
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
-3,039
|
-
|
2,532
|
2,225
|
ROE (net income / shareholders' equity)
|
17.7%
|
26.8%
|
12.7%
|
-
|
13.3%
|
15.5%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
147.0
|
190.0
|
208.0
|
-
|
268.0
|
311.0
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
-
|
-
|
3,086
|
-
|
302
|
500
|
Capex / Sales
|
-
|
-
|
21.99%
|
-
|
1.54%
|
2.21%
|
Announcement Date
|
5/9/19
|
6/23/20
|
5/5/22
|
5/2/24
|
-
|
-
|
Last Close Price
1,172
INR Average target price
1,165
INR Spread / Average Target -0.57% Consensus |
1st Jan change
|
Capi.
|
---|
| +0.27% | 548M | | +17.07% | 66.31B | | +0.18% | 48.46B | | +19.95% | 43.27B | | +27.43% | 27.41B | | +8.30% | 19.26B | | -2.14% | 16.61B | | +8.24% | 16.58B | | -15.01% | 14.41B | | -30.22% | 14.02B |
Other Specialty Chemicals
|